Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei
Open Access
- 1 May 2020
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1), 1-9
- https://doi.org/10.1186/s12885-020-6705-y
Abstract
Background: Familial cases of appendiceal mucinous tumours (AMTs) are extremely rare and the underlying genetic aetiology uncertain. We identified potential predisposing germline genetic variants in a father and daughter with AMTs presenting with pseudomyxoma peritonei (PMP) and correlated these with regions of loss of heterozygosity (LOH) in the tumours. Methods: Through germline whole exome sequencing, we identified novel heterozygous loss-of-function (LoF) (i.e. nonsense, frameshift and essential splice site mutations) and missense variants shared between father and daughter, and validated all LoF variants, and missense variants with a Combined Annotation Dependent Depletion (CADD) scaled score of ≥10. Genome-wide copy number analysis was performed on tumour tissue from both individuals to identify regions of LOH. Results: Fifteen novel variants in 15 genes were shared by the father and daughter, including a nonsense mutation in REEP5. None of these germline variants were located in tumour regions of LOH shared by the father and daughter. Four genes (EXOG, RANBP2, RANBP6 and TNFRSF1B) harboured missense variants that fell in a region of LOH in the tumour from the father only, but none showed somatic loss of the wild type allele in the tumour. The REEP5 gene was sequenced in 23 individuals with presumed sporadic AMTs or PMP; no LoF or rare missense germline variants were identified. Conclusion: Germline exome sequencing of a father and daughter with AMTs identified novel candidate predisposing genes. Further studies are required to clarify the role of these genes in familial AMTs.Keywords
All Related Versions
Funding Information
- Australian National Health and Medical Research Council and Victorian Cancer Council (APP1028374)
- University of Melbourne, Australia (Australian Postgraduate Award)
This publication has 41 references indexed in Scilit:
- Appendix-derived Pseudomyxoma Peritonei (PMP)American Journal of Clinical Oncology, 2018
- Analysis of Mutation and Loss of Heterozygosity by Whole-Exome Sequencing Yields Insights into Pseudomyxoma PeritoneiThe Journal of Molecular Diagnostics, 2018
- Incidence and Survival of Appendiceal Mucinous NeoplasmsAmerican Journal of Clinical Oncology, 2017
- Molecular profiles of high‐grade and low‐grade pseudomyxoma peritoneiCancer Medicine, 2015
- Mucinous epithelial neoplasms of the appendix and pseudomyxoma peritoneiLaboratory Investigation, 2015
- Genomic profile of pseudomyxoma peritonei analyzed using next‐generation sequencing and immunohistochemistryInternational Journal of Cancer, 2014
- GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survivalHuman Pathology, 2014
- Molecular Profiling of Appendiceal Epithelial Tumors Using Massively Parallel Sequencing to Identify Somatic MutationsClinical Chemistry, 2014
- Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal originGenome Medicine, 2014
- Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysisJournal of Human Genetics, 2013